Get Real Time Here
| Open0.695 | Close0.796 |
| Vol / Avg.1.203M / 741.308K | Mkt Cap10.796M |
| Day Range0.651 - 0.800 | 52 Wk Range0.400 - 2.910 |
NeuroSense Therapeutics Stock (NASDAQ:NRSN), Quotes and News Summary
NeuroSense Therapeutics Stock (NASDAQ: NRSN) stock price, news, charts, stock research, profile.
| Open0.695 | Close0.796 |
| Vol / Avg.1.203M / 741.308K | Mkt Cap10.796M |
| Day Range0.651 - 0.800 | 52 Wk Range0.400 - 2.910 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-07-17 | Alliance Global Partners | James Molloy | Initiates Coverage On | Buy | Announces | - | 7.50 |
| 2022-01-07 | Maxim Group | Naz Rahman | Initiates Coverage On | Buy | Announces | - | 7.00 |
How do I buy NeuroSense Therapeutics (NRSN) stock?
You can purchase shares of NeuroSense Therapeutics (NASDAQ: NRSN) through any online brokerage.
Who are NeuroSense Therapeutics's (NRSN) competitors?
There are no as such competitors for NeuroSense Therapeutics.
What is the target price for NeuroSense Therapeutics (NRSN) stock?
The latest price target for NeuroSense Therapeutics (NASDAQ: NRSN) was reported by Alliance Global Partners on Monday, July 17, 2023. The analyst firm set a price target for 7.50 expecting NRSN to rise to within 12 months (a possible 849.37% upside). 1 analyst firms have reported ratings in the last year.
Current Stock Price for NeuroSense Therapeutics (NRSN)?
The stock price for NeuroSense Therapeutics (NASDAQ: NRSN) is $0.79 last updated Today at December 8, 2023 at 12:52 AM UTC.
Does NeuroSense Therapeutics (NRSN) pay a dividend?
There is no dividend information for NeuroSense Therapeutics.
When is NeuroSense Therapeutics (NASDAQ:NRSN) reporting earnings?
NeuroSense Therapeutics’s Q3 earnings are confirmed for Tuesday, November 28, 2023.
Is NeuroSense Therapeutics (NRSN) going to split?
There is no upcoming split for NeuroSense Therapeutics.
What sector and industry does NeuroSense Therapeutics (NRSN) operate in?
NeuroSense Therapeutics is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.